NC
REGN icon

Nicholas Company’s Regeneron Pharmaceuticals REGN Stock Holding History

Nicholas Company’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-14,725
Closed -$7.19M – 222
2020
Q1 		$7.19M Sell
14,725
-1,220
-8% -$503K 0.2% 118
2019
Q4 		$5.99M Hold
15,945
– – 0.13% 175
2019
Q3 		$4.42M Hold
15,945
– – 0.1% 194
2019
Q2 		$4.99M Sell
15,945
-75
-0.5% -$25K 0.11% 191
2019
Q1 		$6.58M Sell
16,020
-965
-6% -$397K 0.16% 149
2018
Q4 		$6.34M Hold
16,985
– – 0.17% 138
2018
Q3 		$6.86M Hold
16,985
– – 0.15% 151
2018
Q2 		$5.86M Sell
16,985
-75,595
-82% -$23.6M 0.14% 163
2018
Q1 		$31.9M Sell
92,580
-160
-0.2% -$55.6K 0.72% 46
2017
Q4 		$34.9M Buy
92,740
+15,955
+21% +$6.46M 0.76% 44
2017
Q3 		$34.3M Buy
76,785
+14,105
+23% +$6.71M 0.76% 49
2017
Q2 		$30.8M Buy
62,680
+48,095
+330% +$21M 0.68% 52
2017
Q1 		$5.65M Hold
14,585
– – 0.13% 140
2016
Q4 		$5.35M Buy
14,585
+20
+0.1% +$7.61K 0.12% 139
2016
Q3 		$5.86M Sell
14,565
-25
-0.2% -$10K 0.13% 125
2016
Q2 		$5.09M Hold
14,590
– – 0.1% 129
2016
Q1 		$5.26M Buy
14,590
+80
+0.6% +$33K 0.11% 121
2015
Q4 		$7.88M Hold
14,510
– – 0.15% 100
2015
Q3 		$6.75M Sell
14,510
-2,005
-12% -$1.08M 0.13% 104
2015
Q2 		$8.42M Hold
16,515
– – 0.15% 105
2015
Q1 		$7.46M Sell
16,515
-8,010
-33% -$3.39M 0.14% 117
2014
Q4 		$10.1M Hold
24,525
– – 0.21% 86
2014
Q3 		$8.84M Hold
24,525
– – 0.21% 92
2014
Q2 		$6.93M Hold
24,525
– – 0.16% 113
2014
Q1 		$7.36M Hold
24,525
– – 0.18% 109
2013
Q4 		$6.75M Buy
24,525
+12,510
+104% +$3.6M 0.16% 119
2013
Q3 		$3.76M Buy
+12,015
New +$3.16M 0.1% 174

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Nicholas Company's REGN Position: Q2 2020 in Review

Nicholas Company sold out of Regeneron Pharmaceuticals (REGN) in Q2 2020, closing a stake of 14,725 shares — an estimated $7.19M sold.

Nicholas Company first reported a position in REGN in Q3 2013 and held it in 27 quarters. The position peaked at $34.9M in Q4 2017. 933 funds tracked by Wall St. Rank hold REGN as of Q2 2020.

  • Nicholas Company reported no remaining Regeneron Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Nicholas Company sold 14,725 Regeneron Pharmaceuticals shares in Q2 2020, an estimated $7.19M.
  • Nicholas Company first reported a position in Regeneron Pharmaceuticals in Q3 2013 and held it in 27 quarters.
  • Nicholas Company's Regeneron Pharmaceuticals position peaked at $34.9M in Q4 2017.
  • 933 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2020.

Based on Nicholas Company's 13F filing for Q2 2020, filed 13 Aug 2020.